Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online November 8, 2007
Diabetes 57:424-431, 2008
DOI: 10.2337/db07-1285
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-1285v1
57/2/424    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hagman, D. K.
Right arrow Articles by Poitout, V.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hagman, D. K.
Right arrow Articles by Poitout, V.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cyclical and Alternating Infusions of Glucose and Intralipid in Rats Inhibit Insulin Gene Expression and Pdx-1 Binding in Islets

Derek K. Hagman1, Martin G. Latour1, Swarup K. Chakrabarti2, Ghislaine Fontes1, Julie Amyot1, Caroline Tremblay1, Meriem Semache1, James A. Lausier3, Violet Roskens3, Raghavendra G. Mirmira2, Thomas L. Jetton3, and Vincent Poitout1,4

1 Montreal Diabetes Research Center, Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Montréal, Quebec, Canada
2 Department of Medicine and the Diabetes Center, University of Virginia, Charlottesville, Virginia
3 Division of Endocrinology, Diabetes and Metabolism, University of Vermont College of Medicine, Burlington, Vermont
4 Departments of Medicine, Nutrition, and Biochemistry, Université de Montréal, Montréal, Quebec, Canada

Address correspondence and reprint requests to Vincent Poitout, DVM, PhD, Montreal Diabetes Research Center, Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Technopole Angus, 2901 Rachel Est, Montréal, QC, H1W 4A4, Canada. E-mail: vincent.poitout{at}umontreal.ca

Key Words: ChIP, chromatin immunoprecipitation • GSIS, glucose-stimulated insulin secretion • NEFA, nonesterified fatty acid • Pdx-1, pancreas-duodenum homeobox-1

OBJECTIVE—Prolonged exposure of isolated islets of Langerhans to elevated levels of fatty acids, in the presence of high glucose, impairs insulin gene expression via a transcriptional mechanism involving nuclear exclusion of pancreas-duodenum homeobox-1 (Pdx-1) and loss of MafA expression. Whether such a phenomenon also occurs in vivo is unknown. Our objective was therefore to ascertain whether chronic nutrient oversupply inhibits insulin gene expression in vivo.

RESEARCH DESIGN AND METHODS—Wistar rats received alternating 4-h infusions of glucose and Intralipid for a total of 72 h. Control groups received alternating infusions of glucose and saline, saline and Intralipid, or saline only. Insulin and C-peptide secretion were measured under hyperglycemic clamps. Insulin secretion and gene expression were assessed in isolated islets, and β-cell mass was quantified by morphometric analysis.

RESULTS—Neither C-peptide secretion nor insulin sensitivity was different among infusion regimens. Insulin content and insulin mRNA levels were lower in islets isolated from rats infused with glucose plus Intralipid. This was associated with reduced Pdx-1 binding to the endogenous insulin promoter, and an increased proportion of Pdx-1 localized in the cytoplasm versus the nucleus. In contrast, MafA mRNA and protein levels and β-cell mass and proliferation were unchanged.

CONCLUSIONS—Cyclical and alternating infusions of glucose and Intralipid in normal rats inhibit insulin gene expression without affecting insulin secretion or β-cell mass. We conclude that fatty acid inhibition of insulin gene expression, in the presence of high glucose, is an early functional defect that may contribute to β-cell failure in type 2 diabetes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.